|
US2019270787A1
|
|
Cysteine variants of interleukin-11 and methods of use thereof
|
|
US2017080055A1
|
|
Hematopoitetic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure
|
|
US2017035852A1
|
|
Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
|
|
US2016244798A1
|
|
Methods for making proteins containing free cysteine residues
|
|
AU2008203051A1
|
|
Derivatives of growth hormone and related proteins
|
|
AU2008202371A1
|
|
Methods for making proteins containing free cysteine residues
|
|
EP2102355A2
|
|
Long acting proteins and peptides and methods of making and using the same
|
|
US2008076706A1
|
|
Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
|
|
US2007111240A1
|
|
Cysteine muteins in the C-D loop of human interleukin-11
|
|
WO2007041614A2
|
|
Long acting vegf inhibitors and methods of use
|
|
AU2006203197A1
|
|
Derivatives of growth hormone and related proteins
|
|
US2009249503A1
|
|
Enzyme conjugates for use as detoxifying agents
|
|
US7270809B2
|
|
Cysteine variants of alpha interferon-2
|
|
AU2002306305B2
|
|
Derivatives of growth hormone and related proteins
|
|
US7153943B2
|
|
Derivatives of growth hormone and related proteins, and methods of use thereof
|
|
CN1443194A
|
|
Methods for refolding proteins containing free cysteine residues
|
|
NZ535718A
|
|
A cysteine variant of an anti-angiogenesis protein where at least one cysteine residue is substituted for at least one amino acid
|
|
EP1200124A1
|
|
Erythropoietin-immunoglobulin fusion proteins
|
|
EP2305804A1
|
|
MonoPEGylated human growth hormone
|
|
BR122013003013B1
|
|
Monopegylated isolated growth hormone protein and method for obtaining it
|
